SCHEMBL1089537

SCHEMBL1089537

CCN(CC)CCNc1nc(N2CCCCC2)c2ccccc2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX1 Q96LB2 1/20 0.59
LMNA P02545 6/20 0.52
MAPT P10636 5/20 0.52
KMT2A Q03164 4/20 0.52
ALDH1A1 P00352 4/20 0.52
MEN1 O00255 3/20 0.52
HTT P42858 3/20 0.52
NPSR1 Q6W5P4 3/20 0.52
HPGD P15428 2/20 0.52
RECQL P46063 2/20 0.52
SMN1; SMN2 Q16637 2/20 0.52
CYP1A2 P05177 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C9 P11712 1/20 0.52
ALOX12 P18054 1/20 0.52
CYP2C19 P33261 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
KDM4E B2RXH2 3/20 0.51
ATM Q13315 2/20 0.51
MAPK1 P28482 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1089154 1.00 MRGPRX1 (0.59) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1089378 1.00 MRGPRX1 (0.59) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1088370 0.99 MRGPRX1 (0.60) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1088774 0.93 MRGPRX1 (0.57) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1088522 0.93 MRGPRX1 (0.57) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1090009 0.93 MRGPRX1 (0.57) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1089720 0.92 MRGPRX1 (0.58) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1090089 0.88 MRGPRX1 (0.61) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1089644 0.88 MRGPRX1 (0.61) MRGPRX1LMNAMAPTKMT2AALDH1A1
SCHEMBL1089641 0.88 MRGPRX1 (0.61) MRGPRX1LMNAMAPTKMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885LMNA 3658/4885MAPT 4748/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885LMNA 3658/4885MAPT 4748/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 MRGPRX1 237/4885LMNA 3658/4885MAPT 4748/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.